Content about Anatomy

INDIANAPOLIS — A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

The biotech manufacturer announced the FDA approval of Prolia (denosumab) to increase bone mass in men with osteoporosis who are at high risk for fracture. The drug already was approved for osteoporosis in postmenopausal women.

LOS ANGELES — Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow. According to one study, about half of all seniors suffer from leg cramps — they’re more common in women (56%) than men (40%). And two drug classes with strong links to leg cramps include diuretics and the inhaled long-acting B2-agonists 
(e.g., Advair, Serevent, Symbicort).

LOS ANGELES — Hair removal brand Nad's has announced the launch of Nad's nose wax for men and women, a complete do-it-yourself nose wax system for removing nose hair.

Containing chamomile and aloe, Nad’s nose wax is applied with the Nad’s Safetip applicator that is designed to target the hair around the edge of the nostril, only removing hairs that are sticking out or easily noticed. The specially formulated wax also can be used to remove blackheads from the nose’s surface.

SILVER SPRING, Md. — According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system) submitted by MSD Consumer. The proposed OTC product would be called Oxytrol for Women and would be indicated for the treatment of overactive bladder in women.

The prescription form of Oxytrol is licensed by Watson Pharma.

INDIANPOLIS — Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

The Lilly Glucagon mobile app is an interactive tool designed to teach caregivers how to use severe hypoglycemia treatment Glucagon (1-mg) for injection through simulated practice, thus helping caregivers better understand Glucagon's role in diabetes management. The Lilly Glucagon mobile app includes:

• Information about severe hypoglycemia and Glucagon;

WASHINGTON — A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

According to published reports, the panel voted 15-2 that the benefits of Humira outweighed the risks in treating ulcerative colitis. However, the panel asked Abbott to conduct more studies upon Humira's approval.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

Wockhardt, based in Mumbai, India, announced the approval of alfuzosin hydrochloride extended-release tablets in the 10-mg strength, which is designed to treat enlarged prostate, also known as benign prostatic hyperplasia.

The drug is a generic version of Sanofi's Uroxatral. Various versions of the drug have sales of about $81.5 million, according to IMS Health.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

According to the American Heart Association, 1-out-of-3 American adults has high blood pressure or hypertension. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure and kidney failure.

False lashes a faux pas? No way! Thanks in large part to celebrities who have popularized false eyelashes and lash extensions, sales of false lashes have been, and continue to be, on the upswing — in a big way.


Pacific World, which currently markets Revlon-branded false lashes, is looking to bring its Eyelene lash brand to the U.S. market in 2013. Eyelene currently is sold in the United Kingdom and Canada.


ALBANY, N.Y. — Mode beauty brand, which was developed by second-generation cosmetics purveyors Cristina Samuels and Jennifer Isaac, has created the new Natural Skin High Performance Hydrating foundation.